These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37883248)

  • 1. Naloxone Telephone Outreach Program in an Outpatient Mental Health Clinic: A Quality Improvement Project.
    Huang JN; Gerardi M; Yeargain O; Senterfitt T; Saldiva M
    Issues Ment Health Nurs; 2023 Dec; 44(12):1265-1271. PubMed ID: 37883248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone acceptance by outpatient veterans: A risk-prioritized telephone outreach event.
    Wu S; Frey T; Wenthur CJ
    Res Social Adm Pharm; 2021 May; 17(5):1017-1020. PubMed ID: 32980236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing risk index for overdose or serious opioid-induced respiratory depression (RIOSORD) scores to prioritize offer of rescue naloxone in an outpatient veteran population: A telephone-based project.
    Yates D; Frey T; Montgomery JC
    Subst Abus; 2018; 39(2):182-184. PubMed ID: 29578839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An initiative to increase opioid overdose education and naloxone distribution for homeless veterans residing in contracted housing facilities.
    Rife T; Tat C; Jones J; Pennington DL
    J Am Assoc Nurse Pract; 2021 Mar; 34(1):188-195. PubMed ID: 33731554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of Pharmacy Student Interns into a Naloxone Telephone Outreach Service.
    Rothbauer K; Genisot A; Frey T; JohnsonPharmacy William S Middleton Memorial Veterans Hospital D
    J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):208-215. PubMed ID: 35997489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
    Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
    Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacist involvement in expanding naloxone distribution in a veteran population.
    McQuillan A
    Am J Health Syst Pharm; 2022 Mar; 79(6):472-476. PubMed ID: 34755851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdose education and naloxone distribution for veterans with opioid use disorder: Results from a pilot initiative.
    Chang G; Davids M; Kershaw A
    J Addict Dis; 2017; 36(4):217-221. PubMed ID: 28548574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispensing a Naloxone Kit at Hospital Discharge: A Retrospective QI Project.
    Train MK; Patel N; Thapa K; Pasho M; Acquisto NM
    Am J Nurs; 2020 Dec; 120(12):48-52. PubMed ID: 33214374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of pharmacist contact via telephone vs letter on rate of acquisition of naloxone rescue kits by patients with opioid use disorder.
    Hoefling AD; Ash LR; Linneman TW
    Subst Abus; 2021; 42(4):625-629. PubMed ID: 32881647
    [No Abstract]   [Full Text] [Related]  

  • 11. Naloxone Distribution and Training for Patients with High-Risk Opioid Use in a Veterans Affairs Community-Based Primary Care Clinic.
    Raffel KE; Beach LY; Lin J; Berchuck JE; Abram S; Markle E; Patel S
    Perm J; 2018 Mar; 22():. PubMed ID: 29616917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telephone-based opioid overdose education and naloxone distribution (OEND) pharmacy consult clinic.
    Szydlowski EM; Caruana SS
    Subst Abus; 2018; 39(2):145-151. PubMed ID: 31032747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.
    Ellis MS; Kasper ZA; Gold M; Cicero TJ
    J Addict Med; 2023 Mar-Apr 01; 17(2):197-205. PubMed ID: 36148998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
    Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
    Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a Veterans Affairs Medical Center.
    Pauly JB; Vartan CM; Brooks AT
    Subst Abus; 2018; 39(2):206-210. PubMed ID: 29565760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in naloxone prescriptions in a University Hospital during the COVID-19 pandemic.
    Chieh K; Patel I; Walter L; Li L
    Harm Reduct J; 2022 Jul; 19(1):84. PubMed ID: 35883136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.